Dementia Risk and Vitamin D

In this episode, we explore methadone maintenance therapy for opioid use disorder, covering dosing strategies, recent regulatory changes, and safety considerations. Why do so many patients fail on methadone despite its proven effectiveness, and how can proper dosing make the diff ... Show More

In this episode, we explore the puzzling connection between clozapine and obsessive-compulsive symptoms in schizophrenia patients. Does this wonder drug actually cause OCD, or are we missing a deeper story about how protective behaviors transform into compulsive habits? Faculty: ... Show More

In this episode, we explore groundbreaking head-to-head research comparing topiramate and naltrexone for alcohol use disorder, revealing surprising equivalence in effectiveness. Could the off-label option actually be as good as our FDA-approved standard for treating problematic d ... Show More

This episode is a conversation with Dr. Lucette Cysique about long COVID. We discuss terminology, symptom profiles, epidemiology, biological mechanisms, psychological and sociocultural factors, overlap with chronic fatigue syndrome, overlap with functional neurological disorder, ... Show More

As I've been researching and writing Boundless 2.0, I've found myself reevaluating many of the health and fitness strategies that I previously endorsed.In this episode, prepare to have your perspective challenged as I discuss some of the significant shifts in thinking I've underg ... Show More

Sam Harris speaks with Dr. Jennifer Mitchell and Dr. Sarah Abedi about recent developments in research on psychedelics. They discuss the history of this research and the war on drugs, recent setbacks in the FDA approval process, MDMA as a treatment for post-traumatic stress disor ... Show More

This podcast episode is all about the brain because the guest is master clinician, certified neuropsychiatrist, and brain scientist, Dr. David Feifel.Feifel founded the Kadima Neuropsychiatry Institute in San Diego after having been a professor of psychiatry at UC San Diego for m ... Show More

Ozempic. Developed as diabetes medication. Adopted as a weight loss drug. Eyed for its potential neuroprotective effects. Hollywood’s popularization of Ozempic as a way to lose weight has made it one of the most widely-discussed drugs of our time, and has put immense stress on su ... Show More

In this enlightening episode, Alison sits down with EMDR expert, Taylor Klump, to debunk common misconceptions about Eye Movement Desensitization and Reprocessing (EMDR) and how to determine if you’re the right candidate for this transformative therapy. Taylor also introduces us ... Show More

In this Huberman Lab Essentials episode, I answer your most frequently asked questions about science-backed tools for improving alertness, enhancing learning, and achieving quality sleep. I also discuss the optimal times for exercising and eating, how to properly time light expos ... Show More

Lipid Drugs: Part 1   Guest: Alicia A. Mickow, APRN, C.N.P., M.S.N Host: Stephen L. Kopecky, M.D.   In Part 1 of this two-part series, listeners will learn the challenges of managing patients who are statin-intolerant, the range of available treatment options, alternative dosing ... Show More

In this episode, Joe interviews Thomas Feegel: co-founder of Beond Ibogaine, an ibogaine treatment and research facility in Cancún, Mexico. When Feegel first heard of ibogaine 16 years ago, he found that people were having great success, but nobody could recommend where to go for ... Show More

On this week's episode of the pod, we are talking about a drug that's been available for decades but is suddenly being pulled from shelves: phenylephrine (something you've probably reached for when you've been congested). We bring on an expert, Dr. Mikkael Sekeres, a Professor of ... Show More